All Stories

  1. Targeting PBK with small-molecule 1- O -acetyl-4 R ,6 S -britannilactone for the treatment of neuroinflammation

    Article • Proceedings of the National Academy of Sciences, July 2025, Proceedings of the National Academy of Sciences

    Bruce Hammock

  2. Metabolomics reveals soluble epoxide hydrolase as a therapeutic target for high-sucrose diet-mediated gut barrier dysfunction

    Article • Proceedings of the National Academy of Sciences, November 2024, Proceedings of the National Academy of Sciences

    Bruce Hammock

  3. sEH-derived metabolites of linoleic acid drive pathologic inflammation while impairing key innate immune cell function in burn injury

    Article • Proceedings of the National Academy of Sciences, March 2022, Proceedings of the National Academy of Sciences

    Bruce Hammock

  4. Kurarinone alleviated Parkinson's disease via stabilization of epoxyeicosatrienoic acids in animal model

    Article • Proceedings of the National Academy of Sciences, February 2022, Proceedings of the National Academy of Sciences

    Bruce Hammock

  5. Eicosanoid regulation of debris-stimulated metastasis

    Article • Proceedings of the National Academy of Sciences, October 2021, Proceedings of the National Academy of Sciences

    Bruce Hammock

  6. Resolution of eicosanoid/cytokine storm prevents carcinogen and inflammation-initiated hepatocellular cancer progression

    Article • Proceedings of the National Academy of Sciences, August 2020, Proceedings of the National Academy of Sciences

    Bruce Hammock

  7. Development of a noncompetitive idiometric nanobodies phage immumoassay for the determination of fumonisin B1

    Article • Food and Agricultural Immunology, January 2019, Taylor & Francis

    Bruce Hammock

  8. Phage-displayed nanobody based double antibody sandwich chemiluminescent immunoassay for the detection of Cry2A toxin in cereals

    Article • Food and Agricultural Immunology, January 2019, Taylor & Francis

    Bruce Hammock

  9. Celecoxib Does Not Protect against Fibrosis and Inflammation in a Carbon Tetrachloride–Induced Model of Liver Injury

    Article • Molecular Pharmacology, May 2018, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Bruce Hammock

  10. Developments on Immunoassays for Pyrethroid Chemicals

    Article • Current Organic Chemistry, January 2018, Bentham Science Publishers

    Bruce Hammock

  11. Modulation of innate immunity of patients with Alzheimer’s disease by omega-3 fatty acids

    Article • The FASEB Journal, April 2017, Federation of American Societies For Experimental Biology (FASEB)

    Professor Matteo Pellegrini, Bruce Hammock

  12. Soluble Epoxide Hydrolase Pharmacological Inhibition Decreases Alveolar Bone Loss by Modulating Host Inflammatory Response, RANK-Related Signaling, Endoplasmic Reticulum Stress, and Apoptosis

    Article • Journal of Pharmacology and Experimental Therapeutics, March 2017, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Bruce Hammock

  13. Anti-Ulcer Efficacy of Soluble Epoxide Hydrolase Inhibitor TPPU on Diclofenac-Induced Intestinal Ulcers

    Article • Journal of Pharmacology and Experimental Therapeutics, March 2016, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Bruce Hammock

  14. The 2014 Bernard B. Brodie Award Lecture—Epoxide Hydrolases: Drug Metabolism to Therapeutics for Chronic Pain

    Article • Drug Metabolism and Disposition, March 2015, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Bruce Hammock

  15. Cloning and characterization of two glutathione S‐transferases from pyrethroid‐resistant Culex pipiens

    Article • Pest Management Science, January 2012, Wiley

    Bruce Hammock